Add Yahoo as a preferred source to see more of our stories on Google. The epinephrine nasal spray is now approved for emergency treatment of Type I allergic reactions, including anaphylaxis, in adult ...

Please provide your email address to receive an email when new articles are posted on . Fears associated with needles may cause patients and caregivers to delay their use of epinephrine autoinjectors.

The U.S. Food and Drug Administration approved a new nasal spray on Friday to treat emergency allergic reactions in adults and children — the first injection-free alternative to shots like EpiPen. The ...

In a Stanford Medicine-led study, patients whose sense of smell was affected by COVID-19 were helped by injections of platelet-rich plasma derived from their own blood. Credit: Unsplash/CC0 Public ...

By Hugo Francisco de Souza A novel nasal booster approach may help close the gap between systemic vaccination and infection-blocking mucosal immunity, offering fresh insight into next-generation COVID ...

Please provide your email address to receive an email when new articles are posted on . Intranasal spray had faster and higher maximum concentrations than autoinjectors and manual syringes. The spray ...

You have probably been there yourself. In the emergency room, on the ski slope or at the ice rink, with a child who is in great pain. Their wrist is swollen and broken. Tears are flowing, and ...